Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Generation and homing of iPSC-derived hematopoietic cells in vivo.

Literature DB >> 23812546

Generation and homing of iPSC-derived hematopoietic cells in vivo.

Bin-Kuan Chou¹, Zhaohui Ye, Linzhao Cheng.

Abstract

Mesh：

Year: 2013 PMID： 23812546 PMCID： PMC3702102 DOI： 10.1038/mt.2013.129

Source DB: PubMed Journal: Mol Ther ISSN： 1525-0016 Impact factor: 11.454

× No keyword cloud information.

9 in total

1. The terminology of teratocarcinomas and teratomas.

Authors: Ivan Damjanov; Peter W Andrews
Journal: Nat Biotechnol Date: 2007-11 Impact factor: 54.908

2. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.

Authors: Dan Ran; Wei-Jong Shia; Miao-Chia Lo; Jun-Bao Fan; David A Knorr; Patrick I Ferrell; Zhaohui Ye; Ming Yan; Linzhao Cheng; Dan S Kaufman; Dong-Er Zhang
Journal: Blood Date: 2013-01-31 Impact factor: 22.113

Review 3. Promise and challenges of human iPSC-based hematologic disease modeling and treatment.

Authors: Zhaohui Ye; Bin-Kuan Chou; Linzhao Cheng
Journal: Int J Hematol Date: 2012-05-23 Impact factor: 2.490

4. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors.

Authors: Michael Kyba; Rita C R Perlingeiro; George Q Daley
Journal: Cell Date: 2002-04-05 Impact factor: 41.582

5. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation.

Authors: Nao Suzuki; Satoshi Yamazaki; Tomoyuki Yamaguchi; Motohito Okabe; Hideki Masaki; Satoshi Takaki; Makoto Otsu; Hiromitsu Nakauchi
Journal: Mol Ther Date: 2013-05-14 Impact factor: 11.454

Review 6. Lessons from human teratomas to guide development of safe stem cell therapies.

Authors: Justine J Cunningham; Thomas M Ulbright; Martin F Pera; Leendert H J Looijenga
Journal: Nat Biotechnol Date: 2012-09 Impact factor: 54.908

7. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells.

Authors: Giovanni Amabile; Robert S Welner; Cesar Nombela-Arrieta; Anna Morena D'Alise; Annalisa Di Ruscio; Alexander K Ebralidze; Yevgenya Kraytsberg; Min Ye; Olivier Kocher; Donna S Neuberg; Konstantin Khrapko; Leslie E Silberstein; Daniel G Tenen
Journal: Blood Date: 2012-12-04 Impact factor: 22.113

8. Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk.

Authors: Satoshi Takaki; Hatsue Morita; Yoshinari Tezuka; Kiyoshi Takatsu
Journal: J Exp Med Date: 2002-01-21 Impact factor: 14.307

Review 9. Reprogrammed cells for disease modeling and regenerative medicine.

Authors: Anne B C Cherry; George Q Daley
Journal: Annu Rev Med Date: 2013 Impact factor: 13.739

9 in total

5 in total

Generation and homing of iPSC-derived hematopoietic cells in vivo.

1. The terminology of teratocarcinomas and teratomas.

2. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.

Review 3. Promise and challenges of human iPSC-based hematologic disease modeling and treatment.

4. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors.

5. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation.

Review 6. Lessons from human teratomas to guide development of safe stem cell therapies.

7. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells.

8. Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk.

Review 9. Reprogrammed cells for disease modeling and regenerative medicine.

Review 1. Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cells.

Review 2. Murine models of hepatitis C: what can we look forward to?

Review 3. Genomic editing tools to model human diseases with isogenic pluripotent stem cells.

Review 4. In Vivo Model Systems for Hepatitis B Virus Research.

5. Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T-ALL.